The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...
Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...
Unless they have been taught how to use their dry-powder inhalers, patients may not be getting any medication, a German pulmonologist reports. Siegfried Wieshammer, MD, studied 224 consecutive asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results